Oncolytics Biotech Inc T.ONC

New trial update on FDA/Multiple melanoma

[canadafan]

Few are even aware onc was involved with BMS with a multiple melanoma trial.
They just added National cancer INstitute & another agency as colaborators.
Also note in the consent form, It clearly states both ONC & BMS are splitting the cost of the trial.


https://www.clinicaltrials.gov/ct2/history/NCT03605719?A=9&B=10&C=merged#StudyPageTop


Perhaps this will be the news/pre-Friday Q1 update?
Could be a little soon, depends what they discovered.

The Winship MM study has been off the investor update page for months.
Adding the N.C.I. , could mean nothing. The again, why advance the involvment with bad news.

[jimsenior]

@canadafan. Hello. I must correct you. MM is Multiple Myeloma. Thank you for the pointing this out. I believe both NIH & NCI got added, and I think it is noteworthy. MM is still very much a part of ONC/Y. Best.

[canadafan]

I'm not one on spelling. the point is the same regardless of how I annouciated the word. .

[jimsenior]

@CF. I was not criticizing you. This was not the first time you made this mistake. Multiple Myeloma is a devastating illness, and patients deserve a correct spelling. It is not a skin cancer. I very much appreciated your bringing the addition of these 2 agencies to our attention. MM is a very important piece of this puzzle. The AMBUSH trial is also very interesting indeed. I read your posts with

[canadafan]

My feelings not hurt at all. spelling for me has been a life long challenge. that said, I read extremely fast & significant vocabulary. I have been called direct names from people on various boards. Somewhat meaningless as they have no idea who I am or anything about me. I try very hard to post exact, real traceable information about Onc. One guy called me a liar & a cheat, because I

[Lesalpes29]

I unserstand you Canadafan... not easy for Jimsenior to understand! Forget that kind of useless post. MOST understood what you were talking about. GL

[Geneman2004]

The myleoma story is getting long-toothed. Lots of patients treated and plenty of clinical evidence of some effect. Treating relapsed MM with Pela is aimed at extending the effectiveness of current meds and they are trying to be included in earlier treatment. Quite a good model to follow for treatment effect as you can measure residual disease with blood and urine proteins as well as cellular

[Noteable]

"I would think it is actually significantly positive" - Yep

[Eileen68]

Geneman - in your view which is more likely to happen first - AA based on Ind 213 and bracelet or finalizing a deal with BP? Also, are you familiar with the Car-T story? It seems that tech is worth something?